Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polymorphism, Single Nucleotide | 25 | 2017 | 767 | 0.860 |
Why?
|
| Breast Feeding | 1 | 2023 | 113 | 0.810 |
Why?
|
| Genome-Wide Association Study | 11 | 2017 | 333 | 0.740 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2017 | 643 | 0.650 |
Why?
|
| Self Care | 1 | 2016 | 159 | 0.510 |
Why?
|
| Patient Education as Topic | 1 | 2016 | 215 | 0.500 |
Why?
|
| Sleep Apnea, Obstructive | 5 | 2012 | 52 | 0.500 |
Why?
|
| Health Education | 1 | 2016 | 338 | 0.450 |
Why?
|
| Telemedicine | 1 | 2016 | 182 | 0.440 |
Why?
|
| Coronary Disease | 5 | 2014 | 124 | 0.410 |
Why?
|
| Genetic Loci | 6 | 2015 | 90 | 0.380 |
Why?
|
| Genetic Predisposition to Disease | 11 | 2016 | 628 | 0.380 |
Why?
|
| Genotype | 16 | 2017 | 730 | 0.370 |
Why?
|
| Genome, Human | 6 | 2012 | 135 | 0.330 |
Why?
|
| Electrocardiography | 4 | 2016 | 156 | 0.330 |
Why?
|
| Triglycerides | 4 | 2012 | 138 | 0.320 |
Why?
|
| Cholesterol, HDL | 6 | 2014 | 97 | 0.300 |
Why?
|
| Female | 30 | 2023 | 20969 | 0.280 |
Why?
|
| Humans | 39 | 2023 | 37093 | 0.250 |
Why?
|
| Stroke | 3 | 2014 | 286 | 0.250 |
Why?
|
| Florida | 2 | 2023 | 410 | 0.250 |
Why?
|
| Middle Aged | 22 | 2017 | 10129 | 0.240 |
Why?
|
| Chromosome Mapping | 6 | 2011 | 188 | 0.240 |
Why?
|
| Lipoproteins, HDL | 2 | 2015 | 46 | 0.230 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2023 | 36 | 0.220 |
Why?
|
| Adiponectin | 2 | 2013 | 55 | 0.210 |
Why?
|
| Body Mass Index | 7 | 2015 | 854 | 0.210 |
Why?
|
| Phenotype | 11 | 2015 | 689 | 0.200 |
Why?
|
| Insulin Resistance | 3 | 2013 | 184 | 0.200 |
Why?
|
| Male | 29 | 2017 | 20025 | 0.200 |
Why?
|
| Mothers | 1 | 2023 | 181 | 0.190 |
Why?
|
| Cholesterol, LDL | 4 | 2014 | 68 | 0.190 |
Why?
|
| Obesity | 4 | 2015 | 1067 | 0.190 |
Why?
|
| Infant, Newborn | 1 | 2023 | 894 | 0.180 |
Why?
|
| Mendelian Randomization Analysis | 3 | 2014 | 12 | 0.180 |
Why?
|
| Lipids | 2 | 2012 | 235 | 0.180 |
Why?
|
| Infant | 1 | 2023 | 1046 | 0.170 |
Why?
|
| Aged | 17 | 2014 | 6741 | 0.170 |
Why?
|
| Linkage Disequilibrium | 4 | 2011 | 85 | 0.170 |
Why?
|
| Alcohol Drinking | 2 | 2014 | 519 | 0.170 |
Why?
|
| Alleles | 7 | 2016 | 321 | 0.160 |
Why?
|
| Genetic Variation | 4 | 2013 | 387 | 0.160 |
Why?
|
| Adult | 18 | 2015 | 11712 | 0.130 |
Why?
|
| BRCA2 Protein | 1 | 2016 | 37 | 0.130 |
Why?
|
| Genetic Association Studies | 5 | 2014 | 114 | 0.130 |
Why?
|
| Heart Ventricles | 1 | 2016 | 110 | 0.130 |
Why?
|
| Gallbladder Diseases | 1 | 2015 | 3 | 0.130 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2015 | 73 | 0.130 |
Why?
|
| Dopamine beta-Hydroxylase | 2 | 2006 | 9 | 0.130 |
Why?
|
| Child | 1 | 2023 | 3131 | 0.130 |
Why?
|
| Homeodomain Proteins | 1 | 2016 | 132 | 0.130 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2014 | 5 | 0.130 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2014 | 10 | 0.120 |
Why?
|
| Rural Population | 1 | 2016 | 294 | 0.120 |
Why?
|
| Pilot Projects | 1 | 2016 | 661 | 0.120 |
Why?
|
| Quantitative Trait Loci | 2 | 2012 | 77 | 0.120 |
Why?
|
| Cohort Studies | 7 | 2015 | 1492 | 0.120 |
Why?
|
| Sleep | 1 | 2015 | 152 | 0.120 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 77 | 0.120 |
Why?
|
| Lipid Metabolism | 2 | 2015 | 119 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 190 | 0.110 |
Why?
|
| Endothelin-1 | 1 | 2013 | 55 | 0.110 |
Why?
|
| Genealogy and Heraldry | 1 | 2012 | 5 | 0.110 |
Why?
|
| Blood Pressure | 2 | 2014 | 646 | 0.110 |
Why?
|
| Neoplasms | 1 | 2023 | 1103 | 0.110 |
Why?
|
| Models, Genetic | 2 | 2004 | 172 | 0.110 |
Why?
|
| Lipoproteins, LDL | 1 | 2012 | 62 | 0.110 |
Why?
|
| Body Weight | 1 | 2014 | 434 | 0.100 |
Why?
|
| Gene Frequency | 5 | 2012 | 195 | 0.100 |
Why?
|
| Risk Factors | 7 | 2015 | 3562 | 0.100 |
Why?
|
| Crossing Over, Genetic | 1 | 2011 | 5 | 0.100 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2011 | 3 | 0.100 |
Why?
|
| Cholesterol | 1 | 2012 | 205 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2011 | 7 | 0.100 |
Why?
|
| Circadian Rhythm | 1 | 2013 | 225 | 0.090 |
Why?
|
| Sodium Channels | 1 | 2011 | 67 | 0.090 |
Why?
|
| Alcoholism | 1 | 2013 | 240 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 664 | 0.090 |
Why?
|
| Atherosclerosis | 1 | 2011 | 134 | 0.090 |
Why?
|
| Long QT Syndrome | 1 | 2009 | 13 | 0.090 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2009 | 21 | 0.090 |
Why?
|
| Case-Control Studies | 3 | 2013 | 1130 | 0.080 |
Why?
|
| Leukocyte Count | 1 | 2008 | 77 | 0.080 |
Why?
|
| Leptin | 1 | 2009 | 118 | 0.080 |
Why?
|
| Aged, 80 and over | 5 | 2014 | 2379 | 0.080 |
Why?
|
| Polysomnography | 3 | 2015 | 42 | 0.080 |
Why?
|
| Odds Ratio | 3 | 2014 | 534 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 935 | 0.070 |
Why?
|
| Pedigree | 4 | 2011 | 79 | 0.070 |
Why?
|
| Mississippi | 3 | 2010 | 122 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2004 | 4 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2010 | 583 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2004 | 9 | 0.060 |
Why?
|
| Genetic Heterogeneity | 1 | 2004 | 9 | 0.060 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2004 | 17 | 0.060 |
Why?
|
| Smoking | 1 | 2011 | 940 | 0.060 |
Why?
|
| Prevalence | 3 | 2017 | 1455 | 0.060 |
Why?
|
| Meta-Analysis as Topic | 2 | 2014 | 30 | 0.060 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2003 | 26 | 0.060 |
Why?
|
| Longitudinal Studies | 3 | 2014 | 885 | 0.050 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2006 | 282 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2015 | 306 | 0.050 |
Why?
|
| Myocardium | 2 | 2016 | 235 | 0.050 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 225 | 0.050 |
Why?
|
| Blood Glucose | 2 | 2014 | 353 | 0.050 |
Why?
|
| California | 1 | 2023 | 476 | 0.050 |
Why?
|
| Genetics, Population | 2 | 2011 | 100 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 1502 | 0.040 |
Why?
|
| Lod Score | 3 | 2004 | 9 | 0.040 |
Why?
|
| Sex Factors | 3 | 2012 | 898 | 0.040 |
Why?
|
| Genetic Markers | 2 | 2014 | 142 | 0.040 |
Why?
|
| Age Factors | 1 | 2002 | 1033 | 0.040 |
Why?
|
| Gene Expression | 2 | 2012 | 674 | 0.040 |
Why?
|
| Prognosis | 2 | 2011 | 739 | 0.040 |
Why?
|
| Algorithms | 2 | 2011 | 465 | 0.040 |
Why?
|
| Young Adult | 3 | 2014 | 4268 | 0.040 |
Why?
|
| Minority Groups | 1 | 2023 | 596 | 0.040 |
Why?
|
| Haplotypes | 2 | 2011 | 182 | 0.040 |
Why?
|
| Coronary Vessels | 1 | 2017 | 85 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 448 | 0.030 |
Why?
|
| Adolescent | 3 | 2014 | 5363 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2016 | 57 | 0.030 |
Why?
|
| Lipoproteins | 1 | 2015 | 64 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2015 | 83 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2014 | 75 | 0.030 |
Why?
|
| Microsatellite Repeats | 2 | 2004 | 59 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2004 | 8 | 0.030 |
Why?
|
| Fasting | 1 | 2014 | 54 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 2014 | 54 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 268 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2014 | 180 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2006 | 550 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2014 | 153 | 0.030 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2013 | 63 | 0.030 |
Why?
|
| Risk | 1 | 2013 | 267 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 336 | 0.030 |
Why?
|
| Waist-Hip Ratio | 1 | 2012 | 34 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2013 | 208 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 562 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2013 | 455 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2012 | 68 | 0.030 |
Why?
|
| Insulin | 1 | 2014 | 236 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 67 | 0.030 |
Why?
|
| Africa, Western | 1 | 2011 | 18 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2011 | 28 | 0.020 |
Why?
|
| Europe | 1 | 2011 | 101 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2011 | 91 | 0.020 |
Why?
|
| Probability | 1 | 2011 | 78 | 0.020 |
Why?
|
| Systems Biology | 1 | 2011 | 22 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2011 | 89 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 1742 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2011 | 61 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2011 | 36 | 0.020 |
Why?
|
| Lipid Metabolism Disorders | 1 | 2010 | 4 | 0.020 |
Why?
|
| Epidemiologic Studies | 1 | 2010 | 31 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 275 | 0.020 |
Why?
|
| Georgia | 1 | 2010 | 174 | 0.020 |
Why?
|
| Receptors, Nicotinic | 1 | 2011 | 106 | 0.020 |
Why?
|
| Incidence | 1 | 2013 | 922 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 1378 | 0.020 |
Why?
|
| Genomics | 1 | 2011 | 223 | 0.020 |
Why?
|
| Heart Rate | 1 | 2011 | 253 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2011 | 268 | 0.020 |
Why?
|
| Software | 1 | 2011 | 217 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2011 | 177 | 0.020 |
Why?
|
| Base Sequence | 1 | 2011 | 997 | 0.020 |
Why?
|
| Computational Biology | 1 | 2011 | 293 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 360 | 0.020 |
Why?
|
| Linear Models | 1 | 2009 | 275 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2008 | 11 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 1568 | 0.020 |
Why?
|
| United States | 1 | 2017 | 4223 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 923 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2009 | 583 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2009 | 513 | 0.020 |
Why?
|
| Hypertension | 1 | 2013 | 796 | 0.020 |
Why?
|
| Heart Failure | 1 | 2009 | 235 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2004 | 10 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2004 | 9 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2004 | 27 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 2004 | 26 | 0.010 |
Why?
|
| Chromosomes, Human | 1 | 2004 | 35 | 0.010 |
Why?
|
| Family Health | 1 | 2004 | 56 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2004 | 117 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2002 | 6 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2003 | 191 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2011 | 1908 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2009 | 2721 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 935 | 0.010 |
Why?
|